Your current portfolio consists of several big winners. Case in point being Neuland, SBCL, etc.
Laurus probably was one of the most discussed stocks on VP . And one of the biggest and quickest winners for a lot of boarders. About the miss on your front, I think the thing you need to take to heart is that a great company may not necessarily always be a great investment. Laurus in 2020 was a great investment as it was fairly valued as compared to the tailwinds it was facing. And once all the positives were reflected in the price, upsides were limited. And at such a price even a small dose of bad news is enough to change the trend.
A simple exercise we as investors need to carry out in our investments. We need to put up our expected earnings for next couple of years (based on our understanding of the business) and see if those too are priced in at current prices. If that’s the case, its better to atleast lighten up if not sell fully. When prices go up the narrative surrounding the company is so strong, and often management commentary is equally strong. ( Many a times managements are also carried away by price appreciation, they too are human. )
The other small exercise one can do is to learn basics of stage analysis. Its not as difficult as it sounds. When stocks break down from range at top, its easy to see and one can act accordingly.
The current portfolio looks to be pharma heavy. Its okay for now as pharma is seeing some resurgence and its reflected in prices of good pharma companies which are showing good growth. More than 50% of your allocation is to pharma sector. At some point , you will have to take a call on sectoral allocation. Rest seems okay. Best wishes.
| Subscribe To Our Free Newsletter |
